NGLFINENSENGL Fine-Chem Limited· Pharmaceuticals & BiotechnologyHighPositive
Announced Thu, 22 May, 2025 · 21:20 IST

NGL Fine-Chem Limited has informed the Exchange that Record date for the purpose of Dividend is 12-Aug-2025.

NGLFINE · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reactionminutes from the announcement price · days from the prior close
-2.0%Reaction day
₹1284.90
prior close
—
announcement price
After-mkt
timing
Nifty Microcap 250market · in no size index; the smallest one is used+0.7%-2.7% vs market
Pharmaceuticals peers, median of 148sector+0.1%-2.1% vs sector

On the reaction day the stock moved 2.7 pts less than Nifty Microcap 250 and 2.1 pts less than its Pharmaceuticals peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.

Minutes after the announcementfrom the announcement price · no benchmark
Stock
5m
—
10m
—
15m
—
30m
—
Sessions after the filingfrom the prior close
StockMarketvs marketSectorvs sector
Reaction day
-2.0+0.7-2.7+0.1-2.1
Next day
-4.0+1.2-5.2+0.5-4.5
2d
-5.9+1.2-7.0+0.7-6.6
3d
-7.7+1.5-9.2+0.5-8.3
4d
-9.6+1.8-11.4+1.0-10.6
5d
-11.4+2.1-13.5+0.8-12.2
1w
-14.8+1.9-16.7+0.3-15.0
15d
-18.3+3.6-21.9+1.4-19.7
1m
-22.6+1.3-23.9-2.8-19.8
2m
-0.4+6.6-6.9+1.4-1.8
3m
+12.0+2.6+9.4-0.7+12.8
UpDownMarket · Nifty Microcap 250Sector · Pharmaceuticals peers, median of 148Pending

Minute windows have no benchmark: there is no intraday index history to compare against.

AI summary

NGL Fine-Chem's Board (meeting held May 22, 2025) approved a final dividend of Rs. 1.75 per equity share (face value Rs. 5) for FY25, subject to shareholder approval at the AGM on August 19, 2025. The record date is August 12, 2025, and dividend will be paid on or after August 26, 2025. Audited consolidated FY25 revenue grew to Rs. 376.89 crores from Rs. 352.82 crores, but profit after tax fell sharply to Rs. 21.12 crores from Rs. 41.32 crores (down ~49% YoY); standalone PAT dropped to Rs. 18.13 crores from Rs. 38.52 crores. EPS (consolidated) fell to Rs. 34.19 from Rs. 66.88. The Board also appointed Mr. Rahul Nachane as Managing Director (effective June 1, 2025), Mr. Sudhir Deo as Independent Director, and reappointed various auditors.

Likely market impact

Despite a healthy top-line, the near-halving of profits is a red flag that may weigh on the stock in the short term. The Rs. 1.75 dividend offers some return to shareholders, but the payout looks thin relative to the sharply lower earnings. Investors should focus on the profit decline and watch the AGM for any management commentary on margin pressure.